Lung Cancer
News
Pembrolizumab paired with immunostimulator is safe and tolerable
Combining an immunostimulator with pembrolizumab had good tolerability and safety, in a small phase Ib study.
News
ELCC: Survey reveals worldwide underuse of EGFR-mutation testing
Key clinical point: A significant minority of advanced lung cancer patients worldwide fail to receive initial treatment guided by EGFR-mutation...